Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.

Researchers from MIT have developed a 3D-printable tissue adhesive that demonstrates superior tissue adhesion, rapid sealing capabilities across various surgical scenarios and a unique blood-repelling ...

Biological tissues have a remarkable ability to organize and change shape, driven by forces generated by their own cells. One of the major challenges in bioengineering is harnessing this natural ...

In the realm of biomedical sciences, the quest for accurate and efficient diagnostic tools is ever-evolving. One such promising innovation making waves is the photoacoustic (PA) technique. In the past ...

About 25 million people in the U.S.—roughly eight out of 100—are diagnosed with asthma. Allergens, air pollution, extreme ...

YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...

Matrigel is the most commonly used biomaterial for bioengineering tissues from hPSCs. However, its origins from mouse sarcoma come with significant drawbacks, including poor definability, ...

CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort ...

Emily Miller is a fifth year Biomedical Engineering (BME) PhD student conducting research in Dr. Corey Neu's Soft Tissue Bioengineering Lab. She will defend her dissertation in summer 2024. What ...

An implantable tissue flap containing muscle and fat alongside a hierarchical network of blood and lymphatic vessels could offer hope for patients with severe tissue damage. An international research ...